| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050454A1 Moisturizing agent |
| 04/22/2009 | EP2050453A1 Pharmaceutical combinations of meloxicam, tramadol and paracetamol |
| 04/22/2009 | EP2050434A1 Moisturizing agent |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049495A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/22/2009 | EP2049122A1 Methods and compositions for inhibiting angiogenesis |
| 04/22/2009 | EP2049092A2 Compositions with enhanced elasticizing activity |
| 04/22/2009 | EP1670488B1 Process for the application of oxygen to the skin |
| 04/22/2009 | EP1598079B1 Remedies for allergic contact dermatitis |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | CN101415731A Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same |
| 04/22/2009 | CN101415699A Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 04/22/2009 | CN101415441A Healing composition |
| 04/22/2009 | CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 04/22/2009 | CN101411878A Method for anchoring growth factor on material with biodegradability |
| 04/22/2009 | CN101411843A Medicament for eliminating toxic and side effects of chemoradiotherapy |
| 04/22/2009 | CN101411837A Chinese medicine external-use tinctura for treating athlete's foot |
| 04/22/2009 | CN101411826A Internal-use medicament for treating psoriasis |
| 04/22/2009 | CN101411805A Pure natural lozenge for resisting network radiation |
| 04/22/2009 | CN101411803A External use medicament for treating psoriasis |
| 04/22/2009 | CN101411793A Medicament for pathogenic wind-toxic beriberi |
| 04/22/2009 | CN101411769A Medicament for treating beriberi and preparation method thereof |
| 04/22/2009 | CN101411756A Detoxication and stagnation-eliminating medicament |
| 04/22/2009 | CN101411750A Oral Chinese medicine for treating chronic urticaria |
| 04/22/2009 | CN101411745A Antibiotic tanshinone extract, preparation method thereof, use and products produced thereby |
| 04/22/2009 | CN101411731A Hypericuin perforatum L. extract and preparation method thereof |
| 04/22/2009 | CN101411730A Use of oak extract in preparing medicament for treating epidermis injury of person |
| 04/22/2009 | CN101411729A Oak extract and uses thereof |
| 04/22/2009 | CN101411695A External-use bactericidal medicine for skin and mucous membrane |
| 04/22/2009 | CN101411683A Breast cream absorbed by skin |
| 04/22/2009 | CN101411370A Hair tonic tea for preventing and stopping alopecia |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479840C Red burn ointment |
| 04/22/2009 | CN100479832C Medicine for treating burn and scald |
| 04/22/2009 | CN100479820C Itraconazole liposome and preparation process thereof |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521422 Use of aspartic proteases in cosmetics and therapeutics |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049208A1 Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents |
| 04/16/2009 | WO2009049172A1 Methods and compositions for treating dermatological diseases and conditions |
| 04/16/2009 | WO2009048123A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 04/16/2009 | WO2009048119A1 Medicinal composition containing highly functionalized chimeric protein |
| 04/16/2009 | WO2009047826A2 Pharmaceutical composition comprising sucralphate and mesalazine |
| 04/16/2009 | WO2009047618A1 Cosmetic and/or dermatological compositions and use thereof for depigmentation |
| 04/16/2009 | WO2009047562A1 Methods and compositions for the treatment of pruritus |
| 04/16/2009 | WO2009047481A1 Method & composition for the treatment of acne and sebum dependent pilosebaceous disorders |
| 04/16/2009 | WO2009046874A1 Therapeutic combination of trh-potentiating peptide and stresscopin |
| 04/16/2009 | WO2009046872A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046530A1 Compositions affecting hyaluronic acid mediated activity |
| 04/16/2009 | WO2009017646A3 Compositions comprising human collagen and human elastin and methods for soft tissue augmentation |
| 04/16/2009 | WO2009016379A3 Nr4a agonists ( 6-mercaptopurine) for inhibition of non-ocular scarring |
| 04/16/2009 | WO2008067027A3 Compositions of chkl inhibitors and cyclodextrin |
| 04/16/2009 | WO2007030145A3 Elastin protective polyphenolics and methods of using the same |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099257 Composition and process for treating acne |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099202 External Preparation for Athlete's Foot Treatment |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099122 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE EPITHELIAL CELL GROWTH |
| 04/16/2009 | US20090099100 Compositions and methods for treating amyloidosis |
| 04/16/2009 | US20090099093 Peptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090099091 Oligopeptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090098226 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/16/2009 | US20090098221 Creatine ascorbyl derivatives and methods of use thereof |
| 04/16/2009 | US20090098219 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith |
| 04/16/2009 | US20090098216 Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 04/16/2009 | US20090098214 Skin-revitalizing cosmetic composition |
| 04/16/2009 | US20090098213 Pain relief and soothing cream and method for making same |
| 04/16/2009 | US20090098194 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 04/16/2009 | US20090098083 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/16/2009 | US20090098069 Transdermal, alcohol-free, pharmaceutical compositions |
| 04/16/2009 | DE102008009752A1 Beverage for improving the state of health, contains chili pepper juice and grape fruit juice that are mixed to the beverage without alcohol |
| 04/16/2009 | CA2740200A1 Methods and compositions for treating dermatological diseases and conditions |
| 04/16/2009 | CA2702366A1 Compositions affecting hyaluronic acid mediated activity |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2047866A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 04/15/2009 | EP2047865A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2047844A2 A method of microencapsulation |
| 04/15/2009 | EP2046948A1 Activated fibroblasts for treating tissue and/or organ damage |
| 04/15/2009 | EP2046787A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 04/15/2009 | EP2046775A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 04/15/2009 | EP2046764A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 04/15/2009 | EP2046740A1 Compounds having crth2 antagonist activity |
| 04/15/2009 | EP2046737A2 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 04/15/2009 | EP2046407A1 Implantable preparation, useful more particularly for tissue complement and cicatrisation |